Mild to Moderate Persistent Allergic Rhinitis Clinical Trial
Official title:
A Phase III, Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis With Eurofarma Mometasone or Reference Mometasone.
The primary objective will be to compare the impact of the study formulations on alergic rhinitis carriers.
n/a